Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBG1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
mRNA | KCNQ4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | SLC25A40 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | TMEM19 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | PRIMPOL | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | RP11-293I14.2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
mRNA | ELOVL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | PIM2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |